Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UNIPROT:P01889 (
ankylosing spondylitis
)
5,717
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
The distribution of
fibronectin
, an extracellular matrix glycoprotein which plays a part in fibrosis and tissue repair, has previously been described using immunohistochemical methods. These do not differentiate between locally synthesised and plasma derived
fibronectin
. In this work the distribution of cells actively synthesising
fibronectin
was assessed by in situ hybridisation using a radiolabelled antisense RNA probe in synovial biopsy samples from patients with rheumatoid arthritis, osteoarthritis,
ankylosing spondylitis
, and control subjects without inflammatory disease. Large amounts of fibronectin mRNA were found specifically in synovial lining cells, providing evidence for the local production of
fibronectin
in the synovium. Levels of fibronectin mRNA were variable between patients. These differences were not related to the diagnosis or to the subintimal inflammatory cell infiltrate; where there was synovial lining cell hyperplasia there was a concomitant increase in the number of cells containing fibronectin mRNA, which was consistent with increased levels of immunoreactive
fibronectin
at this site. Increased levels of
fibronectin
in synovial fluid in patients with rheumatoid arthritis may be due to an increased number of lining cells secreting the protein, rather than upregulation of the gene by these cells.
...
PMID:Localisation of fibronectin mRNA in the rheumatoid synovium by in situ hybridisation. 161 56
A group of 103 patients with radiologic changes of sacroiliitis were investigated and followed up over a mean period of 3.5 years. The biologic explorations (nonspecific inflammatory tests, humoral immunologic determinations and serum
fibronectin
assay) as well as sacroiliac and spine radiographic examinations, were repeated every 6th-12th months. In 32 patients (31%) clinical, biologic and radiologic signs of evolutive disease, were detected. In such cases, sacroiliitis representing in fact a form of onset of
ankylosing spondylitis
, the HLA-B27 phenotype was also determined and was found present in 8 cases. Of the biologic tests the decrease of serum
fibronectin
proved the most significantly correlated with evolutive tendency of sacroiliitis.
...
PMID:Clinico-biologic aspects and evolutive tendencies in sacroiliitis. 227 Apr 24
The localisation of
fibronectin
in the synovial membrane of rheumatoid arthritis (RA) and other chronic inflammatory joint diseases has been studied using a peroxidase-antiperoxidase immunohistochemical method. Synovia were studied from seven cases of seropositive RA three cases of seronegative RA, six cases of
ankylosing spondylitis
, four cases of Reiter's syndrome and five of psoriatic arthritis. Six were small biopsies and the remaining tissues were obtained at open surgery for orthopaedic procedures or biopsies.
Fibronectin
was demonstrated in all of the synovia examined and was present in intimal cells, synovial giant cells, the walls of small blood vessels, basement membrane of larger vessels and deposits of fibrin. No difference in this distribution of
fibronectin
was found in seropositive and seronegative RA,
ankylosing spondylitis
, Reiter's syndrome or psoriatic arthritis, neither was there any difference in the amount of
fibronectin
at various sites.
...
PMID:Fibronectin in the synovium of chronic inflammatory joint disease. 637 32
Fibronectin
, a human fibroblast surface and plasma protein, is present in cryoprecipitates of synovial fluids and/or sera from patients with rheumatoid arthritis, systemic lupus erythematosus,
ankylosing spondylitis
, and mixed essential cryoglobulinemia.
Fibronectin
was shown to be capable of influencing cryoprecipitate formation. No antibodies to
fibronectin
could be detected, thus ruling out the possibility that it was directly involved in the formation of cold-insoluble antigen--antibody complexes. Fibrinogen or fibrinogen degradation products were frequently present in synovial fluid cryoprecipitates but rarely in serum cryoprecipitates. Since complexes of
fibronectin
--fibrin--fibrinogen are known to be cold-insoluble, such interactions could occur in synovial fluids and contribute to the formation of cryoprecipitates. In serum, however, this is not likely to occur, and the mechanism by which
fibronectin
influences cryoprecipitate formation remains to be elucidated.
...
PMID:The influence of fibronectin on cryoprecipitate formation in rheumatoid arthritis and systemic lupus erythematosus. 731 15